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Abstract 
Background 
In 2013 the Joint British Diabetes Societies published an update to their 2010 
guideline on the management of diabetic ketoacidosis (DKA). In 2014 a national 
survey was conducted to assess the management of DKA across the UK using the 
JBDS or local guidelines. Hospitals were invited to submit data on 5 people 
presenting with DKA. These data were published in 2016. However, whether those 
national results were applicable to individual hospitals remains unknown. 
Aim 
To assess the management of people presenting with DKA at a single hospital and 
compare the results with the national dataset. 
Methods 
Using the identical data collection tool as used in the national survey we collected 
information on 40 subjects (a total of 52 admissions) admitted with DKA between 
April 2014 and July 2015.  
Results 
The data collected locally were very similar to those found in the national dataset. 
The management of DKA was best during the first few hours after admission, then 
biochemical and physical monitoring frequency decreased.  The number of people 
who developed hypokalaemia and hypoglycaemia were very similar to the national 
data. Rates of biochemical improvement were slightly better locally. 
Conclusions 
The data from the national DKA survey, even though based on a maximum of 5 
people per hospital from across the UK are applicable at a hospital level.  
  
Introduction  
Diabetic ketoacidosis (DKA) is a potentially life-threatening metabolic complication 
predominantly affecting people with type 1 diabetes. It usually requires hospital 
admission, and has an appreciable mortality rate [1]. In an attempt to standardise the 
management of DKA, in 2010 the Joint British Diabetes Societies (JBDS) produced a 
guideline that has been widely used [2]. These nationally accepted guidelines 
standardised the criteria for the diagnosis of DKA as a blood glucose concentration 
of >11.0 mmol/L or a known diagnosis of diabetes mellitus; a pH of <7.3; and 
significant ketonuria (>2+) or ketonaemia >3.0mmol/L. They were updated in 2013 
[3], and this update formed the basis of a national survey carried out in 2014 [4,5]. 
 
The national DKA survey reported the results from 72 UK hospitals assessing their 
adherence to the JBDS (or local) guidelines in the management of up to 5 
consecutive patients presenting to their institution. Initial monitoring and 
management with adequate fluid resuscitation and use of weight-based fixed-rate 
intravenous insulin infusion was found to be excellent [4]. However, the quality of 
subsequent care was found to be suboptimal, with significant numbers of patients 
experiencing hypokalaemia and hypoglycaemia (55% and 27.6% respectively).   
However, these data are from a small number of individuals at any one hospital and 
what remains uncertain is if the results of the national survey are applicable to a 
single institution. Thus, the current study was carried out to assess the 
generalisability and reliability of the national survey results to a single institute. 
 
 
 
  
Patients and methods 
We performed a retrospective analysis of patients presenting to our hospital with a 
confirmed diagnosis of DKA between April 2014 and July 2015. The aim was to 
compare our local data to that published in the national survey. Patients were found 
using the hospital Patient Administration System, or using the electronic discharge 
summaries, and also using the records of the diabetes inpatient specialist nurse 
records. They would see all patients admitted with DKA under the Best Practice 
Tariff arrangement [6].  
 
To allow direct comparison of outcomes, the data collection questionnaire utilised in 
the national survey was also used in this audit (Appendix 1). This questionnaire was 
based on the JBDS guideline and collated information on the management of DKA 
from the time of admission to post-discharge. This also included data on biochemical 
and clinical monitoring, as well as those on the adherence to the national guidelines. 
All patient data were obtained by five of the authors. Data were anonymised and 
stored in password protected files and were analysed using SPSS software (IBM Ltd, 
Portsmouth, UK). 
 
The survey was registered with the Clinical Audit and Improvement Department of 
the NNUH NHS Foundation Trust. No ethical approval was required because this 
was deemed to be a service improvement exercise. 
 
  
  
Results 
40 patients were assessed, with a total of 52 admissions. The demographics of the 
patients are compared in Table 1.  
 
There was a greater female preponderance in the local data, and a majority of 
people classified as ‘White’ ethnicity.   
 
Management in the first hour (Table 2) 
 
Locally, 100% of DKA diagnoses were made in accordance with the JBDS 
guidelines, compared to only 71.4% nationally. In addition, all patients locally were 
seen by a senior trainee or consultant.  More people locally were given a ‘stat’ insulin 
dose compared to national data and fewer people received the recommended initial 
fluid replacement of choice. The majority of the other measured parameters were in 
line with national data. However, three other variables had marked differences. Foot 
examination was performed much more frequently in patients locally compared to 
nationally (71.2% vs 33.9% respectively). However, urea and electrolyte 
concentrations (78.8% vs 98.9%) and chest X-ray (42.3% vs 69.3%) were performed 
much less frequently locally than nationally. 
 
Biochemical changes in first 24 hours (Figures 1a – 1c) 
 
These were very broadly similar between the local and national data. Admission 
mean pH (±SD) was 7.15(±0.17) locally, and 7.16 (±0.15) nationally, the mean 
glucose was 29.4 mmol/l (±19.0) locally and 28.7 mmol/l (±10.9) nationally. Mean 
  
blood ketone concentration was 5.06 mmol/l (±1.6) locally, 5.68 mmol/l (±1.5) 
nationally. Mean bicarbonate was 13.3 mmol/l (±6.2) locally, and 11.3 mmol/l (±5.1) 
nationally. The mean potassium on admission was 5.0 mmol/l (±1.2) locally and 4.8 
mmol/l (±1.0) nationally. Figures 1a, 1b and 1c show the changes in potassium, pH, 
and bicarbonate concentrations during the course of the 24 hours following 
admission showing very similar rates of change between the local and national data.  
 
Adherence to guidelines (Table 3) 
 
The management of patients after the initial hour to 24 hours is shown in Table 3.  
23.1% of patients did not have potassium replaced as per local guidelines. This 
finding is similar to the national findings in which 20.1% of respondents felt that 
potassium replacement was not carried out in accordance with their guidelines. This 
also reflects in the percentage of patients whose potassium levels remained in the 
reference ranges (local - 44.2%, national - 43.1%). However, fixed rate intravenous 
insulin infusions were given appropriately with accordance to the guidelines more 
frequently locally (98.1%), than nationally (90.5%). In addition, more people locally 
(88.5%) had an appropriate established monitoring regimen than nationally (70.3%).  
 
Fewer patients locally developed hypoglycaemia - 13.5% vs 27.6% nationally. The 
other major difference was the percentage of patients reviewed by a senior if 
progress was unsatisfactory (locally 90.4% vs nationally 33.2%).  
  
  
 
Resolution and on-going in-hospital management (Table 4) 
 
Figure 1 shows the rate of biochemical resolution was slightly faster locally, with the 
mean pH reaching 7.3 at 6 hours (just over 7 hours nationally), and the mean 
bicarbonate concentration reaching 15.0mmol/l at 4 hours (just under 6 hours 
nationally).  The rates of DKA resolution were similar between the two groups. 
However, locally there was much greater monitoring and involvement of senior 
medical staff and the specialist diabetes team during the acute phase of the illness 
than nationally, although after resolution, the rates of diabetes team involvement was 
almost identical.   
 
Discharge planning (Table 5) 
Table 5 shows the steps involved prior to discharge.  
 
Discussion 
This single centre study shows that data from the national survey on the 
management of DKA are applicable to our – and probably other – individual sites.  
 
The original national survey was undertaken to assess the management of DKA 
across the UK [4]. However, by using a very few number of individuals from any one 
institution, there was a risk that when pooled, the data would be nationally 
representative, but may not have been applicable to an individual site. In addition, 
whist the original survey had asked for consecutive admissions to be included, there 
was the risk of selection bias from sites when choosing whose data to submit.   
  
 
A previous single centre study had been conducted looking at outcomes using the 
first version of the DKA guideline [7]. They also looked at 50 cases of people with a 
discharge code of DKA admitted between February and December 2012. They found 
that 46% of their cohort developed hypokalaemia and that 70% had not had their 
potassium replaced according to the guidelines. In addition, they also found that 40% 
of their cohort experienced hypoglycaemia, with 20% of people not having 10% 
dextrose prescribed correctly [7]. Overall, they found that, as with this study and the 
national survey, the initial management during the first hour after admission 
management was very good. However, it was in the subsequent time that the 
guidelines were not followed as vigorously, with metabolic monitoring, fluid balance 
and hypoglycaemia being areas for concern [4,7]. The authors of that study, and the 
national survey found that diabetes specialist team involvement was high once the 
immediate management period had passed.  
 
There were, however, several issues with the previous local audit that the authors 
themselves acknowledged. They had 172 admissions with DKA, and they chose to 
look at 100 of those. However, they were unable to include several of those into their 
dataset because they had not used the correct prescription chart or proforma, others 
had been admitted directly to the intensive care unit, and several others were coded 
as having DKA but on closer inspection, had other diagnoses. The strength of the 
current study is that we had a consecutive cohort of admissions with a full dataset on 
everyone, with no selection bias.   
 
  
Another strength of the current study is that it looked at the most up to date version 
(2013) of the DKA guideline. Furthermore, the current study used the same data 
collection tool that was used in the national survey allowing for a direct comparison 
to be made, and there were many fewer missing data.  
 
During treatment 51.9% of patients locally developed hypokalaemia and 13.5% 
developed hypoglycaemia. These findings are similar to those found in the national 
survey. However, it is unknown as to whether the guidelines were used when caring 
for those who developed hypokalaemia or hypoglycaemia and those who did not. It 
may well be that to prevent these, the rate of insulin infusion should be halved when 
the glucose or ketone concentrations fall, to reduce the rate of intracellular 
potassium uptake. 
 
A limitation that must be acknowledged is that the lead author of the national 
guideline works at our hospital. It is possible that his presence there influenced the 
junior medical staff at the front door who manage the patients admitted with DKA for 
the first few hours. In addition, several of the senior medical staff in the acute 
medical unit are also trained in diabetes and endocrinology, thus prone to ensure 
greater adherence to the national guideline. This is also likely to have been a factor 
as to why a higher proportion of patients were reviewed by a senior member of staff, 
particularly when metabolic improvement was not being seen.  
  
The process and completion of the discharge were also examined. There were more 
people with diabetes receiving psychological support before being discharged in the 
local study (65% more patients received support). At the time of the data collection 
  
our service had ready access to psychological services, something that has been 
advocated for people with DKA [6]. However soon after the study ended, funding for 
this service was withdrawn. The percentage of correct insulin doses written was also 
higher locally compared to the national study. However, fewer discharge letters 
contained the correct information. In the questionnaire used for this study, other 
questions about discharge were also addressed such as the name of insulin, follow-
up appointments and GP’s receiving care plans. The results showed room for 
improvement across all the discharge fields. Our local data also showed several 
areas that needed improvement. These included that only 40% of people were 
followed up within 30 days; only 7% of discharge plans were sent to the GP; 23% of 
patients did not have ketone testing on discharge; 71.2% of patients did not have 
any written care plan with the diabetes inpatient specialist team; and that 10% of 
patients developed post-discharge complications. These results, in line with the 
national data, suggest that more communication between the patient and the 
specialist team, and between secondary and primary care may need to occur and 
that discharge summaries need to be improved.  
 
In summary, our data have shown that the management of DKA locally was very 
similar to that seen in the 2014 national DKA survey. There remain areas of good 
practice, especially in the first few hours, but that a significant proportion of people 
develop hypokalaemia and hypoglycaemia. These data once again suggest that 
either the guidelines need to be better followed, or that the rate of insulin infusion 
needs to be changed once glucose or ketone concentrations fall. Further work needs 
to be done to decide what the best course of action should be. 
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Legends 
Table 1 
Baseline demographics of patients. National data are taken from reference [4] 
 
Table 2 
Management of the patient in the first hour after diagnosis of DKA was made. The number 
and percentage of missing data for each variable is shown. National data are taken from 
reference [4] 
JBDS – Joint British Diabetes Societies for Inpatient Care Group 
ICU – Intensive Care Unit 
FRIII – Fixed Rate Intravenous Insulin Infusion 
ECG – Electrocardiogram 
CXR – Chest X-Ray 
 
Table 3 
Ongoing management between 1 and 24 hours after the diagnosis of DKA was made. 
National data are taken from reference [4] 
FRIII – Fixed Rate Intravenous Insulin Infusion 
EWS – Early Warning Score 
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Table 4 
Data showing the management of DKA beyond 24 hours, once the resolution of DKA had 
been confirmed.  National data are taken from reference [4] 
s.c. – subcutaneous 
 
Table 5 
Data showing the management of DKA once resolution had been confirmed. National data 
are taken from reference [4] 
GP – General Practitioner 
 
Figure 1a  
Potassium concentrations in people presenting with DKA - National vs Local. The error bars 
are ±1SD 
 
Figure 1b  
pH Values in people presenting with DKA - National vs Local. The error bars are 
±1SD 
 
Figure 1c  
Bicarbonate concentration in people presenting with DKA - National vs Local. The 
error bars are ±1SD 
 
Online Appendix 1 
Questionnaire used in the data collection  
  
Table 1 – Baseline Demographics.  
 
 
 
  
 NNUH National 
Gender %   
Male 32.7 51.9 
Female 67.3 46.3 
Missing data 0 1.8
Ethnicity, %   
White 88.5 81.6 
Mixed white/ Asian or white /black 5.8 0.8 
Indian/Asian 0 1.4 
African /black 1.9 1.5 
Other  2.8 0.4 
Missing data 1 14.5 
  
Table 2  
  
 NNUH National 
Variable Yes % No % 
Missing 
data n (%) 
Yes (%) No (%) 
Missing 
data n (%) 
Was the 
Diagnosis 
Made Using 
JBDS Criteria? 
100 0 0 71.4 18.7 28 (9.9) 
Seen by ICU or 
a Senior? 
100 0 0 85.9 7.1 19 (6.7) 
Was a 'Stat' 
Insulin Dose 
Given? 
48.1 51.9 0 14.8 84.1 3 (1.1) 
Was 0.9% 
Sodium 
Chloride 
Solution Used? 
86.5 13.5 0 96.5 3.2 1 (0.4) 
Was an FRIII 
used? 
90.4 9.6 0 91.5 8.5 0 (0) 
Potassium 
Replacement 
in Accordance 
with Local 
Protocol? 
80.8 19.2 0 79.9 12.9 20 (7.2) 
Early Warning 
Score 
Recorded? 
94.2 3.8 1.9 91.2 3.2 16 (5.7) 
Respiratory 
Rate 
Recorded? 
98.1 1.9 0 96.5 0.4 9 (3.2) 
Temperature 
Recorded? 
100 0 0 95.4 0 13 (4.6) 
Pulse Rate 
Recorded? 
100 0 0 97.2 0 8 (2.8) 
Oxygen 
Saturations 
Recorded? 
100 0 0 97.2 0 8 (2.8) 
Glasgow Coma 
Scale 
82.7 15.4 1.9 89.8 6.7 10 (3.5) 
  
Recorded? 
Full History 
Recorded? 
92.3 7.7 0 95.8 3.2 3 (1.1) 
Full 
Examination 
Recorded? 
92.3 7.7 0 92.6 3.2 11 (3.9) 
Foot 
Examination 
Recorded? 
71.2 25 3.8 33.9 47.7 52 (18.4) 
Blood Ketones 
Recorded? 
90.4 9.6 0 80.9 15.9 9 (3.2) 
Capillary Blood 
Glucose 
Recorded? 
90.4 9.6 0 97.5 0.7 5 (1.8) 
Venous 
Plasma 
Glucose 
Recorded? 
94.2 5.8 0 93.3 4.2 7 (2.5) 
Urea and 
Electrolytes 
Recorded? 
78.8 17.3 3.8 98.9 0 3 (1.1) 
Venous Blood 
Gases 
Recorded? 
94.2 5.8 0 92.9 5.7 4 (1.4) 
Full Blood 
Count 
Performed? 
82.7 13.5 3.8 92.2 3.2 13 (4.6) 
ECG 
Performed? 
73.1 23.1 3.8 79.9 14.1 17 (6.0) 
CXR 
Performed? 
42.3 50 7.7 69.3 23.7 20 (7.1) 
Urinalysis 
Performed? 
59.6 30.8 9.6 74.9 13.1 34 (12) 
 
  
  
Table 3  
 NNUH National 
Variable Yes % No  % 
Missing 
data n (%) 
Yes (%) No (%) 
Missing 
data n (%) 
Was IV 0.9% 
Sodium Chloride 
Solution 
Replacement 
Given as per 
Local 
Guidance? 
90.4 9.6 0 89.4 9.9 2 (0.7) 
Was a FRIII 
used as per 
Local Guidance 
98.1 1.9 0 90.5 7.8 5 (1.8) 
Capillary 
Glucose Levels 
Measured 
Hourly? 
88.5 11.5 0 81.6 13.1 15 (5.3) 
Observations of 
Vital Signs 
taken Hourly? 
82.7 17.3 0 67.8 26.9 15 (5.3) 
EWS measured 
Hourly? 
82.7 17.3 0 67.1 32.5 21 (7.4) 
Urine Output 
Documented? 
78.8 19.2 1.9 74.2 22.6 9 (3.2) 
Was 10% 
Glucose started 
when the 
Glucose 
Dropped to 
<14mmol/l? 
63.5 32.7 3.8 82.7 15.2 6 (2.1) 
Review of Fluid 
Balance with the 
Rate of Normal 
Saline Amended 
if Appropriate? 
94.2 5.8 0 68.9 20.8 29 (10.2) 
Was a Long 
Acting Insulin 
Continued? 
63.5 25 11.5 58.3 38.5 8 (2.8) 
Was there a 
Review of 
86.5 13.5 0 85.9 5.7 22 (7.8) 
  
Metabolic 
Response to 
Treatment? 
If Yes, Were 
Appropriate 
Changes in 
Treatment 
Made? 
88.5 3.8 7.7 58.7 10.2 86 (30.4) 
Was a 
Precipitating 
Cause Found? 
80.8 19.2 0 77.0 13.8 25 (8.8) 
Was a Referral 
to Diabetes 
Team Made? 
98.1 1.9 0 92.6 4.2 9 (3.2) 
 
  
  
Table 4 
 
 NNUH National 
Variable  Yes % No  % 
Missing 
data n (%) 
Yes (%) No (%) 
Missing 
data n (%) 
Was resolution 
of DKA 
confirmed? 
78.8 17.3 3.8 83.1 9.2 22 (7.8) 
Treatment and 
monitoring 
reviewed by 
specialist 
registrar 
/consultant on-
call? 
31.7 48.1 19.2 11.0 67.5 61 (21.6) 
Was the 
specialist 
diabetes team 
involved during 
the acute 
phase?  
100 0 0 13.4 53.0 95 (33.6) 
Was this 
transition to s.c. 
insulin 
managed 
appropriately?  
86.5 3.8 9.6 83.4 12.4 12 (4.2) 
After DKA 
resolution was 
the patient 
reviewed by the 
Diabetes 
Inpatient 
Specialist 
Team? 
94.2 1.9 3.8 95.1 3.9 3 (1.1) 
 
  
  
Table 5  
 NNUH National 
Variable  Yes % No  % 
Missing 
data n (%) 
Yes (%) No (%) 
Missing data 
n (%) 
Did the patient 
receive 
education 
support before 
discharge? 
86.5 11.5 1.9 86.8 8.8 13 (4.6) 
Did the patient 
receive 
psychological 
support before 
discharge? 
73.1 23.1 3.8 8.1 82.7 26 (9.2) 
Did the 
discharge letter 
contain all the 
correct clinical 
information?  
80.8 15.4 3.8 91.2 2.5 17 (6.0) 
Did the 
discharge letter 
contain the 
correct insulin 
dose?  
88.5 5.8 5.8 76.3 15.5 23 (8.1) 
Did the 
discharge letter 
contain the 
correct delivery 
device? 
69.2 19.2 11.5 56.9 32.5 30 (10.6) 
Did the 
discharge letter 
contain the 
correct insulin 
name?  
40.4 30.8 28.8 83.7 8.8 20 (7.1) 
Did follow-up by 
Diabetes 
Inpatient 
Specialist Team 
40.4 30.8 28.8 54.1 31.1 41 (14.5) 
  
take place 
within 30 days?  
Were there any 
post-discharge 
complications 
9.3 79.2 11.5 9.2 83.0 22 (7.8) 
Was there a 
written care 
plan between 
patient and 
Diabetes 
Inpatient 
Specialist 
Team?  
15.4 71.2 13.4 46.6 41.3 34 (12.0) 
Was a copy of 
the care plan 
sent to GP?  
6.8 87.5 5.7 53.4 38.2 24 (8.5) 
Did the patient 
have access to 
ketone testing 
on discharge?  
54.5 22.9 22.6 55.5 26.1 52 (18.4) 
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Figure 1a  
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Figure 1b  
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Highlights 
 
Data from a large national survey on the management of diabetic ketoacidosis (DKA) looked at 
outcomes of up to 5 people presenting to a single institution. However, whether these national data 
are applicable to individual hospitals is unknown 
 
Our data are very similar to the national dataset, showing that the management of DKA was best in 
the first hour and then guidelines were adhered to less often after that. 
 
Work needs to be done to improve adherence to guidelines, and a discussion is necessary as to 
whether the rate of intravenous insulin should be reduced when glucose concentrations drop. 
 
